GlassScriptPhysician profile
Arun K Gupta
NPI 1962444802
$17,317.72
in general payments reported to CMS, 2019-2025
52 companies · $1,169 in 2025
The $1,169 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,430 · 2020: $2,128 · 2021: $3,573 · 2022: $3,438 · 2023: $1,817 · 2024: $1,763 · 2025: $1,169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,679 · Education: $69.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,678.99 |
| Education | $69.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,818.37 | 2019-2025 | Lokelma, Farxiga |
| Janssen Pharmaceuticals, INC | $1,545.19 | 2019-2024 | Xarelto |
| Amgen INC. | $1,364.58 | 2019-2025 | Repatha, Repatha |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,178.98 | 2019-2025 | Xifaxan, Trulance |
| Abbvie INC. | $904.43 | 2019-2024 | |
| Amarin Pharma, INC. | $846.76 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $780.28 | 2019-2024 | Jardiance |
| Pfizer INC. | $747.87 | 2019-2025 | |
| Philips North America LLC | $666.92 | 2022 | |
| Nestle Healthcare Nutrition INC. | $660.83 | 2020-2023 | |
| Redhill Biopharma INC. | $547.83 | 2020-2024 | Talicia, Movantik, Aemcolo |
| Mallinckrodt Hospital Products INC. | $465.21 | 2020-2023 | Acthar |
| Novartis Pharmaceuticals Corporation | $452.07 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $425.00 | 2021-2025 | Verquvo |
| Sanofi-Aventis U.S. LLC | $418.11 | 2019-2023 |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $324.91 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Actelion Pharmaceuticals US, INC. | $300.15 | 2024-2025 | Uptravi, Opsumit |
| Phathom Pharmaceuticals, INC. | $299.52 | 2023-2025 | Voquezna |
| Evoke Pharma, INC. | $272.67 | 2022-2024 | |
| Allergan, INC. | $261.83 | 2019-2020 | |
| Janssen Scientific Affairs, LLC | $249.80 | 2019-2021 | |
| Mylan Specialty L.P. | $244.94 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $235.83 | 2019 | |
| Esperion Therapeutics, INC. | $228.49 | 2021-2024 | Nexletol |
| Glaxosmithkline, LLC. | $190.19 | 2020-2025 | Trelegy Ellipta |
| Boston Scientific Corporation | $178.89 | 2021-2022 | |
| Qol Medical, LLC | $154.35 | 2024 | Sucraid |
| Axsome Therapeutics, INC. | $152.02 | 2023 | Sunosi |
| Intra-Sana Laboratories | $127.25 | 2024 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Insmed, INC. | $121.34 | 2021 | |
| Daiichi Sankyo INC. | $103.83 | 2019-2020 | |
| Cequr Corporation | $100.00 | 2023 | Cequr Simplicity |
| Bayer Healthcare Pharmaceuticals INC. | $98.21 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $95.09 | 2019-2025 | Eliquis |
| Lexicon Pharmaceuticals, INC. | $88.54 | 2023-2024 | Inpefa |
| Medicomp INC | $85.03 | 2022-2025 | Telepatch Cardiac Monitor |
| Alfasigma USA, INC. | $82.09 | 2021 | |
| Janssen Biotech, INC. | $69.66 | 2024-2025 | Tremfya |
| Aimmune Therapeutics, INC. | $65.92 | 2024 | |
| Madrigal Pharmaceuticals | $50.91 | 2025 | Rezdiffra |
| Irhythm Technologies, INC. | $41.00 | 2019-2020 | |
| Baxter Healthcare | $37.48 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Bardy Diagnostics, INC. | $34.34 | 2020-2022 | |
| Shire North American Group INC | $30.23 | 2019 | |
| Gilead Sciences, INC. | $28.51 | 2019 | |
| Lundbeck LLC | $26.00 | 2025 | Vyepti |
| Takeda Pharmaceuticals U.S.A., INC. | $25.66 | 2024 | Entyvio |
| Alexion Pharmaceuticals, INC. | $23.79 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $23.77 | 2019 | |
| Seqirus USA INC | $14.66 | 2019 | |
| Currax Pharmaceuticals LLC | $14.32 | 2025 | Contrave |
| Vistapharm, INC. | $14.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arun Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.